According to the report, global demand for Chronic Pancreatitis Pain market was valued at approximately USD 7.8 billion in 2019, and is expected to generate revenue of around USD 11.1 billion by end of 2026, growing at a CAGR of around 5.2 % between 2020 and 2026.
Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatitis is heavy alcohol consumption. Other causes include hereditary disorders of pancreas, gall stones, cystic fibrosis, certain medication etc. CT scan, magnetic resonance cholangiopancreatography, ultrasound sonography are diagnostic tests used for chronic pancreatitis patients.
Chronic pancreatitis pain market is mostly driven by increasing number of chronic pancreatitis patients across globe. Furthermore, increasing alcohol consumption, torpid lifestyles are contribute towards the growth of chronic pancreatitis pain market. Ongoing research and development in the healthcare literacy rate is expected to open growth avenues for the market over the years.
The report covers forecast and analysis of the chronic pancreatitis pain market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the chronic pancreatitis pain drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides detailed segmentation of the chronic pancreatitis pain drug market based on therapy, and regional segment.
Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends of the market. North America was the leading segment of chronic pancreatitis pain market followed by Europe in 2015 due to continuous increase in alcohol consumption. The chronic pancreatitis pain market is expected to witness the highest growth in the Asia-Pacific region mainly in China and India in the coming years due to the rising population, awareness as well as government initiative in these countries.
Key players in chronic pancreatitis pain market include Abbott, Aptalis Pharma, Inc., McNeil Consumer Healthcare and Sun Biopharma.
This report segments the chronic pancreatitis pain market are:-
Chronic Pancreatitis Pain Market: Type Analysis
Chronic Pancreatitis Pain Market: Regional Analysis
Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatitis is heavy alcohol consumption. Other causes include hereditary disorders of pancreas, gall stones, cystic fibrosis, certain medication etc. CT scan, magnetic resonance cholangiopancreatography, ultrasound sonography are diagnostic tests used for chronic pancreatitis patients.
Chronic pancreatitis pain market is mostly driven by increasing number of chronic pancreatitis patients across globe. Furthermore, increasing alcohol consumption, torpid lifestyles are contribute towards the growth of chronic pancreatitis pain market. Ongoing research and development in the healthcare literacy rate is expected to open growth avenues for the market over the years.
The report covers forecast and analysis of the chronic pancreatitis pain market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the chronic pancreatitis pain drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides detailed segmentation of the chronic pancreatitis pain drug market based on therapy, and regional segment.
Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends of the market. North America was the leading segment of chronic pancreatitis pain market followed by Europe in 2015 due to continuous increase in alcohol consumption. The chronic pancreatitis pain market is expected to witness the highest growth in the Asia-Pacific region mainly in China and India in the coming years due to the rising population, awareness as well as government initiative in these countries.
Key players in chronic pancreatitis pain market include Abbott, Aptalis Pharma, Inc., McNeil Consumer Healthcare and Sun Biopharma.
This report segments the chronic pancreatitis pain market are:-
Chronic Pancreatitis Pain Market: Type Analysis
- Medicinal therapy
- Surgical therapy
- Endoscopic therapy
Chronic Pancreatitis Pain Market: Regional Analysis
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Chronic Pancreatitis Pain Market, 2016 - 2026, (USD Billion)
- 2.2. Chronic Pancreatitis Pain Market: Snapshot
- Chapter 3. Global Chronic Pancreatitis Pain Market – Industry Analysis
- 3.1. Chronic Pancreatitis Pain Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing number of chronic pancreatitis patients
- 3.2.2. Increasing alcohul consumption
- 3.3. Restraints
- 3.3.1. Expensive R&D programs and the need for compliance with regulatory standards
- 3.4. Opportunity
- 3.4.1. Ongoing research and development, and the increasing healthcare literacy rate
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Type segment
- 3.6.2. Market attractiveness analysis by regional segment
- Chapter 4. Global Chronic Pancreatitis Pain Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Chronic Pancreatitis Pain market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Chronic Pancreatitis Pain Product Type launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Chronic Pancreatitis Pain Market – Type Segment Analysis
- 5.1. Global Chronic Pancreatitis Pain market overview: by Type
- 5.1.1. Global Chronic Pancreatitis Pain market revenue share, by Type, 2019 and 2026
- 5.2. Medicinal therapy
- 5.2.1. Global Chronic Pancreatitis Pain market by Medicinal therapy, 2016-2026 (USD Billion)
- 5.3. Surgical therapy
- 5.3.1. Global Chronic Pancreatitis Pain market by Surgical therapy, 2016-2026 (USD Billion)
- 5.4. Endoscopic therapy
- 5.4.1. Global Chronic Pancreatitis Pain market by Endoscopic therapy, 2016-2026 (USD Billion)
- 5.1. Global Chronic Pancreatitis Pain market overview: by Type
- Chapter 6. Global Chronic Pancreatitis Pain Market - Regional Analysis
- 6.1. Global Chronic Pancreatitis Pain market overview: by region
- 6.1.1. Global Chronic Pancreatitis Pain market revenue share, by region, 2019 and 2026
- 6.2. North America
- 6.2.1. North America Chronic Pancreatitis Pain market, by country, 2016-2026 (USD Billion)
- 6.2.2. North America Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.2.3. The U.S.
- 6.2.3.1. The U.S. Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.2.4. Rest of North America
- 6.2.4.1. Rest of North America Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.3. Europe
- 6.3.1. Europe Chronic Pancreatitis Pain market, by country, 2016-2026 (USD Billion)
- 6.3.2. Europe Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.3.3. U.K.
- 6.3.3.1. U.K. Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.3.4. France
- 6.3.4.1. France Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.3.5. Germany
- 6.3.5.1. Germany Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.3.6. Rest of Europe
- 6.3.6.1. Rest of Europe Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Chronic Pancreatitis Pain market, by country, 2016-2026 (USD Billion)
- 6.4.2. Asia Pacific Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.4.3. China
- 6.4.3.1. China Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.4.4. Japan
- 6.4.4.1. Japan Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.4.5. India
- 6.4.5.1. India Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.4.6. Rest of Asia Pacific
- 6.4.6.1. Rest of Asia Pacific Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.5. Latin America
- 6.5.1. Latin America Chronic Pancreatitis Pain market, by country, 2016-2026 (USD Billion)
- 6.5.2. Latin America Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.5.3. Brazil
- 6.5.3.1. Brazil Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.5.4. Rest of Latin America
- 6.5.4.1. Rest of Latin America Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.6. Middle East & Africa
- 6.6.1. Middle East & Africa Chronic Pancreatitis Pain market, 2016-2026 (USD Billion)
- 6.6.2. Middle East & Africa Chronic Pancreatitis Pain market revenue, by Type, 2016-2026 (USD Billion)
- 6.1. Global Chronic Pancreatitis Pain market overview: by region
- Chapter 7. Company Profiles
- 7.1. Abbott.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Aptalis Pharma
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. McNeil Consumer Healthcare
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Sun Biopharma
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Company 5
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Developments
- 7.6. Company 6
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Developments
- 7.7. Company 7
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Developments
- 7.1. Abbott.
